TipRanks
Go Ultimate55% OFF

Ron Bentsur Insider Profile

11 Followers

Ron Bentsur, Chairman & CEO, Director, Ten Percent Owner at Nuvectis Pharma, holds 3.69M shares in Nuvectis Pharma (Ticker: NVCT), holds 144.74K shares in Beyond Air (Ticker: XAIR), holds 0.00 shares in Stemline Therapeutics (Ticker: STML). Most recently, Ron Bentsur Bought ― shares of Nuvectis Pharma on Jul 01, 2026 for an estimated value of $250.00K.

Ron Bentsur's Trading History

NVCT
Nuvectis Pharma
Jul 01, 2026Chairman & CEO, Director, Ten Percent OwnerInformative Buy250.00K$68.16M
XAIR
Beyond Air
Mar 21, 2023DirectorInformative Buy14.90K$324.21K
STML
Stemline Therapeutics
Jun 10, 2020―Uninformative Sell―$0.00
KERX
Keryx Biopharma
Apr 08, 2015―Informative Sell18.59K$2.61M
XTLB
XTL Biopharmaceuticals Sponsored ADR
―CEO―$32.36K

You May Also Like

Ron Bentsur insider profile FAQ

What is the percentage of profitable transactions made by Ron Bentsur?
The percentage of profitable transactions made by Ron Bentsur is 59%.
What is the average return per transaction made by Ron Bentsur?
The average return per transaction made by Ron Bentsur is 14.30%.
What stocks does Ron Bentsur hold?
Ron Bentsur holds: NVCT, KERX, XAIR, STML, XTLB stocks.
What was Ron Bentsur’s latest transaction?
Ron Bentsur’s latest transaction was an Informative Buy of $250.00K.
What was Ron Bentsur's most profitable transaction?
Ron Bentsur’s most profitable transaction was an Informative Buy of NVCT stock on November 6, 2025. The return on the trade was 225.90%.
What is Ron Bentsur's role in Nuvectis Pharma?
Ron Bentsur's role in Nuvectis Pharma is Chairman & CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.